MedPath

Biodegradable Biliary Stent for Post Operative Cystic Duct Leakage

Phase 1
Withdrawn
Conditions
Cyst
Registration Number
NCT00493675
Lead Sponsor
Tampere University
Brief Summary

Endoscopic sphincterotomy and temporary stenting is a routine treatment for post cholecystectomy cystic duct leakage. The draw back is that the plastic stent need to be removed later in a second intervention. Our studies with animal models have demonstrated that biodegradable biliary stent is at least as good as conventional plastic stent to heal that kind of leakage. In this pilot study the biodegradable biliary stent is inserted endoscopically to patients with confirmed cystic duct leakage to demonstrate the efficacy in human setting.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Patients with confirmed post cholecystectomy cystic duct leakage requiring endoscopic treatment
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Clinical healing of bile leakage1 month
Secondary Outcome Measures
NameTimeMethod
Laboratory tests for liver function, ultra sound for bile collections and bile duct diameter and abdominal plain X-ray for stent degradation6 months

Trial Locations

Locations (1)

Tampere University Hospital

🇫🇮

Tampere, Finland

© Copyright 2025. All Rights Reserved by MedPath